Clinical Trial Update: Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition [Phase 1]

View source ↗

Summary

Completed Phase 1 bioequivalence study of Lisinopril 40 mg tablets under fed conditions conducted by IPCA Laboratories Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

Sponsor: IPCA Laboratories Ltd. | Conditions: Fed | Phase 1 | Status: COMPLETED